RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Epidemiology: Endometrial Cancer - Postmenopausal women are at the most risk for developing endometrial cancer; aging populations will drive an increase in cases
Mar 2011 - 24 pages - $5,700
Endometrial Cancer - Pipeline Review, Q3 2011
Jul 2011 - 229 pages - $500
Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Apr 2011 - 103 pages - $2,000
Prostate Cancer Drug Discoveries: What the Future Holds
Nov 2009 - 160 pages - $2,265
Molecular Targeted Cancer Therapies Market Forecast
Aug 2009 - $15,200
Endometrial Cancer Clinical Trials Review, Q4, 2010
Nov 2010 - 55 pages - $1,000
Top 20 Cancer Therapy Brands in Australia Forecast
Mar 2010 - $5,700
Top 20 Cancer Therapy Brands Forecast
Oct 2009 - $15,200
Endometrial Cancer - Pipeline Review, Q1 2011
Jan 2011 - 72 pages - $500
Avastin and the AVADO Trial Survey
Feb 2008 - $2,500
More Related Market Research Reports >>>

Your selection

Therapeutic target
Oncology del
Womb cancer del
Endometrial cancer del
Year
2008 del

Browse By

Industry sector
Academic/Research
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Non-profit org./Government
Pharmaceutical
Research tools
Service

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us